Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 13,306 | 32,416 | 32,124 | 49,172 | 24,043 |
| Operating Income | -13,306 | -32,416 | -32,124 | -49,172 | -24,043 |
| Interest Expense | 1,722 | 1,906 | 1,932 | 1,970 | 1,843 |
| Other Income | 5,891 | 78 | 315 | -668 | 535 |
| Pre-tax Income | -9,137 | -34,244 | -33,741 | -51,810 | -25,351 |
| Income Tax | -91 | 52 | 94 | 78 | -32 |
| Net Income Continuous | -9,046 | -34,296 | -33,835 | -51,888 | -25,319 |
| Net Income | $-9,046 | $-34,296 | $-33,835 | $-51,888 | $-25,319 |
| EPS Basic Total Ops | 0.20 | -2.13 | -2.24 | -3.85 | -1.87 |
| EPS Basic Continuous Ops | 0.21 | -2.13 | -2.24 | -3.85 | -1.86 |
| EPS Diluted Total Ops | 0.20 | -2.13 | -2.24 | -3.85 | -1.87 |
| EPS Diluted Continuous Ops | 0.21 | -2.13 | -2.24 | -3.85 | -1.86 |
| EBITDA(a) | $-12,979 | $-31,940 | $-31,511 | $-48,138 | $-23,073 |